Provista Diagnostics' Series B - IV Round

Provista Diagnostics raised a round of funding on March 21, 2016.

Provista Diagnostics is a privately held molecular diagnostics company focused on developing and commercializing through its dtectDx platform, proprietary diagnostic, prognostic and predictive tests f…

Articles about Provista Diagnostics' Series B - IV Round: